Tag Archive for ‘gastric cancer’
Prophylactic hyperthermic intraperitoneal chemotherapy in gastric cancer
Gastric cancer is an aggressive malignancy with poor overall survival rates as a result, in part, of its predilection for peritoneal dissemination. Peritoneal metastasis (PM) is found in up to 55 to 60 percent of patients at the time of diagnosis by imaging or staging laparoscopy.1,2 In addition, despite multimodality therapy, peritoneal recurrence occurs in […]
Trends in perioperative treatment of gastric cancer 2004–2017: An NCDB analysis
There will be 27,600 new diagnoses of gastric cancer and 11,010 gastric cancer-related deaths in the U.S. in 2020. Most patients with gastric cancer will succumb to their disease, and only those few patients diagnosed at an early stage can expect to be cured.1 Gastric cancer occurs with significantly higher incidence in eastern countries, which […]
Ga-68 imaging changes clinical management of GI and pancreatic neuroendocrine tumors
Ga-68 positron emission tomography has improved the clinical management of gastrointestinal and pancreatic neuroendocrine tumors, and multiple studies are ongoing to define its optimal role in clinical practice.
Gastric cancer: Recent updates in surgical and multimodality therapy
Recently completed and ongoing clinical trials in resectable gastric cancer are summarized.
Defining the optimal treatment of locally advanced gastric cancer
Clinical trial data are examined to help develop a consensus approach for locally advanced gastric cancer.
A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy
This month’s column describes how new technology may improve outcomes for patients diagnosed with gastric cancer, specifically the use of PET scans as a biomarker of preoperative chemotherapy efficacy.
Studies address metabolic image-directed oncologic therapy for gastric cancer
Research findings regarding the effect of metabolic response on gastric cancer are summarized, including the new Alliance 021302 trial.